Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Schwartz Jonathan David
See Remarks at ROCKET PHARMACEUTICALS. Filing since 30 Mar 2022.
CIK 0001726398
Company
Date
Role
Action
Shares
Amount
Of holding
RCKT
ROCKET PHARMACEUTICALS, INC.
18 Nov 2025
See Remarks
Sold at will
2,545
$7.59K
0.8%
RCKT
ROCKET PHARMACEUTICALS, INC.
19 Aug 2025
See Remarks
Sold at will
805
$2.41K
0.4%
RCKT
ROCKET PHARMACEUTICALS, INC.
18 Aug 2025
See Remarks
Sold at will
1,680
$5.15K
0.7%
RCKT
ROCKET PHARMACEUTICALS, INC.
14 Aug 2025
See Remarks
Sold at will
11,161
$33.70K
4.7%
RCKT
ROCKET PHARMACEUTICALS, INC.
20 May 2025
See Remarks
Sold at will
801
$5.16K
0.3%
RCKT
ROCKET PHARMACEUTICALS, INC.
16 May 2025
See Remarks
Sold at will
1,582
$10.33K
0.7%
RCKT
ROCKET PHARMACEUTICALS, INC.
25 Feb 2025
See Remarks
Sold at will
6,532
$69.11K
2.7%
RCKT
ROCKET PHARMACEUTICALS, INC.
21 Nov 2024
See Remarks
Sold at will
3,097
$40.42K
1.9%
RCKT
ROCKET PHARMACEUTICALS, INC.
16 Aug 2024
See Remarks
Sold at will
2,710
$50.14K
1.6%
RCKT
ROCKET PHARMACEUTICALS, INC.
17 May 2024
See Remarks
Sold at will
2,754
$64.31K
1.6%
RCKT
ROCKET PHARMACEUTICALS, INC.
17 Feb 2023
See Remarks
Sold, plan not stated
3,557
$67.80K
3.6%
RCKT
ROCKET PHARMACEUTICALS, INC.
30 Mar 2022
See Remarks
Sold, plan not stated
45,000
$738.65K
20.0%
12 decisions on file.
